These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 12532665

  • 1. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Levi M, Friederich PW, van der Meer J.
    Ned Tijdschr Geneeskd; 2002 Dec 28; 146(52):2534-7. PubMed ID: 12532665
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A.
    Thromb Haemost; 2001 Oct 28; 86(4):954-8. PubMed ID: 11686352
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Recombinant factor VIIa (NovoSeven). A review of current and possible future indications].
    Heuer L, Blumenberg D.
    Anaesthesist; 2002 May 28; 51(5):388-99. PubMed ID: 12125311
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy.
    Petrini P, Klementz G.
    Blood Coagul Fibrinolysis; 1998 Mar 28; 9 Suppl 1():S143-6. PubMed ID: 9819046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun 28; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
    Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, Dolan G, Ingerslev J.
    Haemophilia; 2009 Mar 28; 15(2):501-8. PubMed ID: 19187194
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G, Savidge GF.
    Blood Coagul Fibrinolysis; 1993 Dec 28; 4(6):1031-3. PubMed ID: 8148476
    [Abstract] [Full Text] [Related]

  • 17. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
    Franchini M, Lippi G, Franchi M.
    BJOG; 2007 Jan 28; 114(1):8-15. PubMed ID: 17233855
    [Abstract] [Full Text] [Related]

  • 18. Recombinant activated factor VII as a universal haemostatic agent.
    Hedner U.
    Blood Coagul Fibrinolysis; 1998 Mar 28; 9 Suppl 1():S147-52. PubMed ID: 9819047
    [Abstract] [Full Text] [Related]

  • 19. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
    Smith MP, Ludlam CA, Collins PW, Hay CR, Wilde JT, Grigeri A, Melsen T, Savidge GF.
    Thromb Haemost; 2001 Oct 28; 86(4):949-53. PubMed ID: 11686351
    [Abstract] [Full Text] [Related]

  • 20. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.
    Kavakli K, Makris M, Zulfikar B, Erhardtsen E, Abrams ZS, Kenet G, NovoSeven trial (F7HAEM-1510) investigators.
    Thromb Haemost; 2006 Apr 28; 95(4):600-5. PubMed ID: 16601828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.